Literature DB >> 6126641

Cholinergic and dopaminergic mechanisms in Parkinson's disease after long term levodopa administration.

M D Yahr, C G Clough, K J Bergmann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6126641     DOI： 10.1016/s0140-6736(82)90728-0

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

Review 1.  Clinical pharmacokinetics of anti-parkinsonian drugs.

Authors:  J M Cedarbaum
Journal:  Clin Pharmacokinet       Date:  1987-09       Impact factor: 6.447

2.  Pen injected apomorphine against off phenomena in late Parkinson's disease: a double blind, placebo controlled study.

Authors:  L Ostergaard; L Werdelin; P Odin; O Lindvall; E Dupont; P B Christensen; E Boisen; N B Jensen; S H Ingwersen; M Schmiegelow
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-06       Impact factor: 10.154

Review 3.  Clinical pharmacology of dopamine agonists in Parkinson's disease.

Authors:  K W Lange
Journal:  Drugs Aging       Date:  1998-11       Impact factor: 4.271
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.